GlassScriptPhysician profile
Lamberto O Flores
NPI 1891743845
$2,937.89
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,845 · 2020: $886 · 2021: $144 · 2022: $47.09 · 2023: $16.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,362.86 | 2019-2020 | |
| Applied Medical Resources Corporation | $1,117.54 | 2019 | |
| Abbvie INC. | $219.78 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $61.22 | 2021 | |
| Aspira Women'S Health INC | $47.09 | 2022 | |
| Stryker Corporation | $40.57 | 2019 | |
| Coopersurgical, INC. | $30.29 | 2019 | |
| Ethicon US, LLC | $24.96 | 2020 | |
| Smith+Nephew, INC. | $17.41 | 2020 | |
| Convatec INC. | $16.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lamberto Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.